Healthy Skepticism Library
Items published during the years 1970 to 1979
There are 379 items in the Healthy Skepticism Library that were published during the years 1970 to 1979.
HSL2922
Dyer AE.
Drug information--too much, too little, to whom?
Drug Inf J 1977 Jul-Sep; 11:(3):125-9
HSL2923
Everson RE.
Drug information in perspective.
Drug Inf J 1977 Jul-Sep; 11:(3):146-52
HSL2952
Moser RH.
Advertising and our journal.
Ann Intern Med 1977 Jul; 87:(1):114-5
HSL2951
Cocking C.
The abuse of prescription drugs
Weekend Magazine 1977 Jun 18; 16-19
HSL2934
Larson LN, Smith MC, Sharpe TR, Hy R, Garner DD.
Government regulation and the believability of prescription drug advertising. An application of attribution theory and test of symbolic impact
Drug Intell Clin Pharm. 1977 Jun 01; 11:(6):338-43
HSL1879
Rawlins MD.
The role of the pharmaceutical industry in postgraduate medical education.
Br J Clin Pharmacol 1977 Jun; 4:(3):257-9
HSL2918
Carpenter GE.
New Zealand Institute of Medical Representatives.
N Z Med J 1977 May 11; 85:(587):395-6
HSL2142
Mapes R.
Aspects of British general practitioners' prescribing.
Med Care 1977 May; 15:(5):371-81
HSL2926
Hemminki E.
Content analysis of drug-detailing by pharmaceutical representatives.
Med Educ 1977 May; 11:(3):210-5
http://www.ncbi.nlm.nih.gov/pubmed/865343
HSL2928
Hemminki E, Pesonen T.
An inquiry into associations between leading physicians and the drug industry in Finland.
Soc Sci Med 1977 May; 11:(8-9):501-6
HSL2950
Smith MC.
Where are the blacks in prescription drug advertising?
Medical Marketing & Media 1977 May; 12:(5):47-49
HSL8566
Schwartz P.
Medicine Shoppe: forging a chain out of 180 little apothecaries
American Druggist 1977 May; 175:56-60
HSL2942
Smith MC, Griffin L.
Rationality of appeals used in the promotion of psychotropic drugs. A comparison of male and female models
Soc Sci Med. 1977 Apr 01; 11:(6-7):409-14
HSL8568
Roll GF.
Politics and drug regulation
Medical Marketing and Media 1977 Apr; 12:17-18, 20, 22, 24-26, 28-31
HSL534
Murray-Lyon N.
Communication in medicine: a study of how family doctors obtain information on recent advances in the treatment of rheumatic diseases.
Med Educ 1977 Mar; 11:(2):92-102
HSL2944
Stimson GV.
Do drug advertisements provide therapeutic information?
J Med Ethics 1977 Mar; 3:(1):7-13
HSL8554
Prescription drug industry: pharmaceuticals, medical devices, and diagnostic products
Medical Marketing and Media 1977 Mar; 12:17-55
HSL2949
Prescott LF.
Drug promotion.
Br Med J 1977 Feb 26; 1:(6060):574-5
HSL2916
Bell W.
Needed: alternative to the Compendium of Pharmaceuticals and Specialities.
Can Med Assoc J 1977 Feb 19; 116:(4):349-51
HSL2948
Muller M.
Selling health - or buying favour?
New Scientist 1977 Feb 3; 73:266-268
HSL2941
Smith MC.
Appeals used in advertisements for psychotropic drugs: an exploratory study.
Am J Public Health 1977 Feb; 67:(2):171-3
HSL8567
Gross F.
Pharmaceutical preparations-a challenge!
Deutsche Apotheker Zeitung 1977 Jan 13; 117:47-54
HSL8557
Vigoda D.
Prescription drug price advertising, the pharmacist, and the Supreme Court
Apothecary 1977 Jan-Feb; 89:8-10, 36-37
HSL2085
Becker HS, Geer B, Hughes E, Strauss AM.
Boys in white: student culture in medical schools.
New Brunswick, NJ: Transaction Books 1977
http://www.transactionpub.com/cgi-bin/transactionpublishers.storefront/43018647018be98c9c4dc0a80a7306d6/Product/View/0&2D87855&2D622&2D2
HSL2914
Advertising reform
Journal of the Royal College of General Practitioners 1977; 27:387-389
HSL2915
Pharmaceutical industry is ‘reorienting’ its promotional activities
Canadian Family Physician 1977; 23:262
HSL2917
Bourgouin M.
Include bibliography on ads, says reader
Canadian Family Physician 1977; 23:535-536
HSL2919
Coleman V.
Paper doctors: a critical assessment of medical research
Temple Smith 1977;
HSL2924
Heaton PB.
Include bibliography on ads, says reader
Canadian Family Physician 1977; 23:533, 535
HSL2925
Heller T.
Poor health, rich profits: multinational drug companies and the Third World
Spokesman Books 1977;
HSL2927
Hemminki E, Pesonen T.
The function of drug company representatives.
Scand J Soc Med 1977; 5:(3):105-14
HSL2931
Holmes JD.
Drug costs
New Zealand Medical Journal 1977; 86:349
HSL2939
Sevigny DC.
The ethical pharmaceutical industry and some of its economic aspects: an annotated bibliography
Addiction Research Foundation 1977;
HSL2940
Silverman M.
The epidemiology of drug promotion
International Journal of Health Services 1977; 7:157-166
HSL2945
Turnbull JC.
Needed: alternative to the Compendium of Pharmaceuticals and Specialties
Canadian Medical Association Journal 1977; 116:349, 351
HSL2946
Waldron I.
Increased prescribing of Valium, Librium, and other drugs--an example of the influence of economic and social factors on the practice of medicine.
Int J Health Serv 1977; 7:(1):37-62
HSL2947
MacLayton DW, Garner DD.
Physicians' evaluation of an ideal detailman's attributes
Medical Marketing & Media 1977; 12:(2):22, 24-26, 28-30
HSL13303
Olson JC.
Price as an Informational Cue: Effects on Product Evaluations
Woodside AG, Eds. Consumer and Industrial Buying Behaviour New York: North Holland 1977
http://www.amazon.com/Price-informational-cue-evaluations-marketing/dp/B0006X1ZQE/ref=sr_1_1?ie=UTF8&s=books&qid=1206499505&sr=1-1
HSL2866
Achong MR.
Use of cephalosporins.
Can Med Assoc J 1976 Nov 6; 115:(9):841
HSL17495
Pellegrino ED.
Prescribing and drug ingestion symbols and substances.
Drug Intell Clin Pharm 1976 Nov; 10:(11):624-30
http://www.ncbi.nlm.nih.gov/pubmed/10316505
HSL8570
Dorsey R.
S 2697: a toxic prescription.
JAMA 1976 Sep 13; 236:(11):1255-8
HSL2895
Day RL.
…Up to Eight Hours of Relief… Dissecting and analysing an o-t-c drug advertisement
Journal of the American Pharmaceutical Association 1976 September 01; 16:(9):496-499, 504
HSL2875
Hendeles L.
Need for "counter-detailing" antibiotics.
Am J Hosp Pharm 1976 Sep; 33:(9):918-24
HSL2893
Berlow L.
The pharmacist and television advertising.
J Am Pharm Assoc 1976 Sep; 16:(9):510-2
HSL2894
Cope JD.
The charges against O-T-C medicine advertising--are they deserved?
J Am Pharm Assoc 1976 Sep; 16:(9):500-4
HSL2896
Griffenhagen G.
Can O-T-C advertising ever be justified?
Journal of the American Pharmaceutical Association 1976 Sep; 16:(9):495
HSL2897
Helffrich S.
The broadcaster view O-T-C advertising.
J Am Pharm Assoc 1976 Sep; 16:(9):507-9,
HSL2898
Hodes B.
Are magazine ads for O-T-C drugs based on fact?
J Am Pharm Assoc 1976 Sep; 16:(9):513-5
HSL2899
Rheinstein PH, Mazis MB.
Regulation of O-T-C drug advertising: the FDA "prescription".
J Am Pharm Assoc 1976 Sep; 16:(9):505-6,
HSL2892
Anonymous .
Standards in pharmaceutical advertising
Medical Journal of Australia 1976 Jun 5; 63:(23):855-856
HSL2874
Hemminki E.
Factors influencing drug prescribing--inquiry into research strategy.
Drug Intell Clin Pharm 1976 Jun; 10:(6):321-9
HSL2891
Mburu FM, Smith MC, Wetherbee H.
Humor in prescription drug advertising
Medical Marketing & Media 1976 Jun; 11:(6):38-39, 42, 44-45
HSL2877
Keele G.
A survey of the effects of a drug promotion campaign.
J R Coll Gen Pract 1976 May; 26:(166):382-3
HSL8572
Hammel RW, Holberg PA.
Ban the use of pharmaceutical trademarks?
Medical Marketing and Media 1976 May; 11:28, 30, 32-37
HSL8564
How Roche and the U.K. government reached a settlement on Valium
Australian Journal of Pharmacy 1976 Apr; 57:228-231
HSL2876
Herman CM, Rodowskas CA Jr.
Communicating drug information to physicians.
J Med Educ 1976 Mar; 51:(3):189-96
HSL8575
Abuse of medicines. Part 2. Prescription medicines
Drug Intell Clin Pharm 1976 Feb; 10:94-110
HSL8841
Berstein AH.
Liability for drug reactions
Hospitals 1976 Jan 1; 50:111-112
HSL8840
Rubino SJ.
PSSNY straight talks the FTC on Rx price advertising
NY-Pharm 1976 Jan; 51:9-12
HSL2867
Bates DG.
Reader objects to drug co. sponsorship of CME courses
Canadian Family Physician 1976; 22:815
HSL2868
Cady J.
An estimate of the price effects of restrictions on drug price advertising
Economic Inquiry 1976; 14:493-510
HSL2869
A critical look at the drug industry: how profits distort medicine
1976; 31
HSL2870
Dunne M, Flood M, Herxheimer A.
Clioquinol: availability and instructions for use
Journal of Antimicrobial Chemotherapy 1976; 2:21-29
HSL2871
Eaton G, Parish P.
General practitioners' views of information about drugs.
J R Coll Gen Pract 1976; 26:
HSL2872
Eaton G, Parish P.
Sources of drug information used by general practitioners.
J R Coll Gen Pract 1976; 26:
HSL2873
Hargraves R.
Introduction
Journal of Drug Issues 1976; 6:1-5
HSL2878
Lexchin J.
About those drug ads . . .
Canadian Family Physician 1976; 22:109-110
HSL2879
McCaffery M.
About those drug ads . . .
Canadian Family Physician 1976; 22:110
HSL2880
Morgan AH, Jeffers TA, Petrie JC, Walker W.
Drug advertising in medical journals
British Journal of Clinical Pharmacology 1976; 3:1057-1060
HSL2881
Mosher EH.
Portrayal of women in drug advertising: a medical betrayal
Journal of Drug Issues 1976; 6:72-78
HSL2882
Nelson G.
Advertising and the national health
Journal of Drug Issues 1976; 6:28-33
HSL2883
Petersen B, Kuriansky JB, Konheim CS, Anderson RS, Tesar J, Podell RN, Ho A, Cowan NM.
Television advertising and drug use
American Journal of Public Health 1976; 66:(10):975-978
HSL2884
Schwartzman D.
Promotional expenditures
The Johns Hopkins University Press 1976; 182-211
HSL2885
Silverman M, Lee PR.
Pills, profits & politics
University of California Press 1976;
HSL2886
Singer R.
Ads and readers
Canadian Family Physician 1976; 22:635
HSL2887
Smith MC.
Portrayal of the elderly in prescription drug advertising
The Gerontologist 1976; 16:329-334
HSL2888
Spiller GW.
Ads and readers
Canadian Family Physician 1976; 22:635
HSL2889
Stimson GV.
The extent of advertising of pharmaceutical products.
J R Coll Gen Pract 1976; 26:
HSL2890
Stimson GV.
The use of references in drug advertisements.
J R Coll Gen Pract 1976; 26:
HSL2900
Brooke P.
Promotional parameters: a preliminary examination of promotional expenditures
Journal of Drug Issues 1976; 6:(1):21-27
HSL2901
Choate R, Debevoise N.
Caution! Keep this commercial out of reach of children!
Journal of Drug Issues 1976; 6:(1):91-98
HSL2902
Cope JD.
Television advertising of nonprescription medicines: The case for the defendant
Journal of Drug Issues 1976; 6:(1):85-90
HSL2903
Donegan TJ.
The role of the Federal Trade Commission in regulating drug advertising: 1975 perspective
Journal of Drug Issues 1976; 6:(1):99-104
HSL2904
Halberstam M.
The other side of the coin: another physician views drug advertising
Journal of Drug Issues 1976; 6:(1):9-12
HSL2905
Jensen GF, Christiansen RL.
Drug advertising should be banned: Utah's approach
Journal of Drug Issues 1976; 6:(1):65-71
HSL2906
Kuriansky JB.
TV advertising and abuse of over-the-counter drugs
Journal of Drug Issues 1976; 6:(1):79-84
HSL2907
Nellis M.
Ineffectiveness x Delay = Danger: a public health equation for failure
Journal of Drug Issues 1976; 6:(1):56-59
HSL2908
Pekkanen J.
The impact of promotion on physicians' prescribing patterns
Journal of Drug Issues 1976; 6:(1):13-20
HSL2909
Reinstein P.
A regulator's perception of drug advertising
Journal of Drug Issues 1976; 6:(1):60-64
HSL2910
Rucker TR.
Drug information for practitioners: commercial obligation or social responsibility?
Journal of Drug Issues 1976; 6:(1):43-49
HSL2911
Ruskin A.
Social and regulatory consequences of misleading medical information
Journal of Drug Issues 1976; 6:(1):50-55
HSL2912
Stetler CJ.
Advertising of prescription medicines.
Journal of Drug Issues 1976; 6:(1):34-42
HSL2913
Watson M.
A physician views drug advertising
Journal of Drug Issues 1976; 6:(1):
HSL8574
Stahel AI.
Time for decision
Australian Journal of Hospital Pharmacy 1976; 6:(1):20-21
HSL9087
Silverman MM
The Drugging of the Americas: How Multinational Drug Companies Say One Thing About Their Products to Physicians in the United States and Another Thing to Physicians in Latin America
Berkeley: University Of California Press 1976
http://www.amazon.com/Drugging-Americas-Multinational-Companies-Physicians/dp/0520031229/ref=sr_1_1/102-1249992-1219339?ie=UTF8&s=books&qid=1175307707&sr=1-1
HSL8843
Mixson P.
Britain's nationalized pharmacy: lesson for the U.S.
Drug Topics 1975 Dec 1; 119:21, 26-27
HSL8571
What you should know about the FTC
J Am Pharm Assoc. 1975 Dec; 15:(12):668-77
HSL8842
Smiler BA.
Drugs in dentistry
Medical Marketing and Media 1975 Dec; 10:13-16
HSL2857
Stimson GV.
Information contained in drug advertisements.
BMJ. 1975 Nov 29; 4:(5995):508-9
HSL2856
Jacoby J, Small C.
The FDA approach to defining misleading advertising
Journal of Marketing 1975 Oct; 39:65-73
